Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery
Clinical trial NCT00887861 · COMPLETED
Trial details
- NCT number
- NCT00887861
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-08-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.